Detection and characterization of the new synthetic cannabinoid APP‐BINACA in forensic casework

Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.

(2019) Oya Yeter et al.   Drug Testing and Analysis

Enantiospecific Synthesis, Chiral Separation, and Biological Activity of Four Indazole-3-Carboxamide-Type Synthetic Cannabinoid Receptor Agonists and Their Detection in Seized Drug Samples

(2019) Lysbeth H. Antonides et al.   Frontiers in Chemistry

Comprehensive investigation on synthetic cannabinoids: Metabolic behavior and potency testing, using 5F‐APP‐PICA and AMB‐FUBINACA as model compounds

(2019) David Fabregat‐Safont et al.   Drug Testing and Analysis

In vitro metabolism of the synthetic cannabinoids PX‐1, PX‐2, and PX‐3 by high resolution mass spectrometry and their clearance rates in human liver microsomes

(2019) Travon Cooman et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report)

(2018) Vincenzo Abbate et al.   PURE AND APPLIED CHEMISTRY

Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review

(2017) Barry K. Logan et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Rapid and sensitive screening and confirmation of thirty-four aminocarbonyl/carboxamide (NACA) and arylindole synthetic cannabinoid drugs in human whole blood

(2016) Marykathryn Tynon et al.   Drug Testing and Analysis

The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects

(2015) Jan van Amsterdam et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Detection and Quantification of New Designer Drugs in Human Blood: Part 1 - Synthetic Cannabinoids

(2012) J. Ammann et al.   JOURNAL OF ANALYTICAL TOXICOLOGY